McCarthy Sean A.
SEC insider (Form 3/4/5 filer). CIK 0001654058. CEO at CytomX Therapeutics, Inc. (CTMX). 11 reported Form 4/5 transactions since Sep 2024; latest on Mar 17, 2026. Located in EMERYVILLE, CA.
Companies McCarthy Sean A. has filed insider reports for
- CytomX Therapeutics, Inc. (CTMX): Director, Officer, CEO
McCarthy Sean A.
CIK: 0001654058
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CytomX Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Mar 17, 2026CTMX
CytomX Therapeutics, Inc.
SaleDirect119K shares at avg. $6.42$764K - Feb 2, 2026CTMX
CytomX Therapeutics, Inc.
AwardDirect210K shares- - Nov 6, 2025CTMX
CytomX Therapeutics, Inc.
ExerciseDirect101.8K shares at avg. $1.59$162K - Nov 6, 2025CTMX
CytomX Therapeutics, Inc.
SaleDirect101.8K shares at avg. $4.54$462K - Sep 26, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirectPerformance Stock Units (PSUs)
285K shares- - Sep 26, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
570K shares- - Jun 16, 2025CTMX
CytomX Therapeutics, Inc.
SaleDirect55.5K shares at avg. $2.69$149K - Jun 13, 2025CTMX
CytomX Therapeutics, Inc.
ExerciseDirect150K shares- - Mar 18, 2025CTMX
CytomX Therapeutics, Inc.
SaleDirect37.7K shares at avg. $0.60$23K - Feb 4, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirect180K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 17, 2026 | CTMX CytomX Therapeutics, Inc. | Sale | 118,969 | $6.42 | $764,138 | Direct |
| Feb 2, 2026 | CTMX CytomX Therapeutics, Inc. | Award | 210,000 | - | $0 | Direct |
| Nov 6, 2025 | CTMX CytomX Therapeutics, Inc. | Exercise | 101,793 | $1.59 | $161,851 | Direct |
| Nov 6, 2025 | CTMX CytomX Therapeutics, Inc. | Sale | 101,793 | $4.54 | $461,906 | Direct |
| Sep 26, 2025 | CTMX CytomX Therapeutics, Inc. | Award Performance Stock Units (PSUs) | 285,000 | - | - | Direct |
| Sep 26, 2025 | CTMX CytomX Therapeutics, Inc. | Award Stock Option (Right to Buy) | 570,000 | - | - | Direct |
| Jun 16, 2025 | CTMX CytomX Therapeutics, Inc. | Sale | 55,511 | $2.69 | $149,264 | Direct |
| Jun 13, 2025 | CTMX CytomX Therapeutics, Inc. | Exercise | 150,000 | - | - | Direct |
| Mar 18, 2025 | CTMX CytomX Therapeutics, Inc. | Sale | 37,656 | $0.60 | $22,556 | Direct |
| Feb 4, 2025 | CTMX CytomX Therapeutics, Inc. | Award | 180,000 | - | - | Direct |
1-10 of 11 transactions